Log in to save to my catalogue

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6595532

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey

About this item

Full title

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey

Publisher

Washington, DC: Endocrine Society

Journal title

Journal of the Endocrine Society, 2019-07, Vol.3 (7), p.1321-1334

Language

English

Formats

Publication information

Publisher

Washington, DC: Endocrine Society

Subjects

More information

Scope and Contents

Contents

Abstract
Context
X-linked hypophosphatemia (XLH) is characterized by excess fibroblast growth factor 23 (FGF23), hypophosphatemia, skeletal abnormalities, and growth impairment. We aimed to understand the burden of disease of XLH across the lifespan.
Methods
Responses were collected from adults with XLH and parents/caregivers of a child...

Alternative Titles

Full title

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6595532

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6595532

Other Identifiers

ISSN

2472-1972

E-ISSN

2472-1972

DOI

10.1210/js.2018-00365

How to access this item